{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:28:42Z","timestamp":1795026522781,"version":"4.10.2"},"reference-count":37,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Measurements of hepatic iron concentration (HIC) are important predictors of transfusional iron burden and long-term outcome in patients with transfusion-dependent anemias. The goal of this work was to develop a readily available, noninvasive method for clinical HIC measurement. The relaxation rates R2 (1\/T2) and R2* (1\/T2*) measured by magnetic resonance imaging (MRI) have different advantages for HIC estimation. This article compares noninvasive iron estimates using both optimized R2 and R2* methods in 102 patients with iron overload and 13 controls. In the iron-overloaded group, 22 patients had concurrent liver biopsy. R2 and R2* correlated closely with HIC (r2 \u2265 .95) for HICs between 1.33 and 32.9 mg\/g, but R2 had a curvilinear relationship to HIC. Of importance, the R2 calibration curve was similar to the curve generated by other researchers, despite significant differences in technique and instrumentation. Combined R2 and R2* measurements did not yield more accurate results than either alone. Both R2 and R2* can accurately measure hepatic iron concentration throughout the clinically relevant range of HIC with appropriate MRI acquisition techniques. (Blood. 2005;106:1460-1465)<\/jats:p>","DOI":"10.1182\/blood-2004-10-3982","type":"journal-article","created":{"date-parts":[[2005,4,28]],"date-time":"2005-04-28T20:34:27Z","timestamp":1114720467000},"page":"1460-1465","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":929,"title":["MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients"],"prefix":"10.1182","volume":"106","author":[{"given":"John C.","family":"Wood","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Enriquez","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Ghugre","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Tyzka","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Carson","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin D.","family":"Nelson","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Coates","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and the Department of Radiology, Children's Hospital of Los Angeles, CA; and the Department of Biology, California Institute of Technology, Pasadena, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020071613314604500_REF1","unstructured":"Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major [published erratum appears in N Engl J Med.2000;343: 1740]."},{"key":"2020071613314604500_REF2","doi-asserted-by":"crossref","unstructured":"Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood.1997;89: 739-761.","DOI":"10.1182\/blood.V89.3.739"},{"key":"2020071613314604500_REF3","doi-asserted-by":"crossref","unstructured":"Nielsen P, Engelhardt R, Duerken M, Janka GE, Fischer R. Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases. Transfus Sci.2000;23: 257-258.","DOI":"10.1016\/S0955-3886(00)00101-6"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry. Br J Haematol.2003;121: 938-948.","DOI":"10.1046\/j.1365-2141.2003.04297.x"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Fischer R, Tiemann CD, Engelhardt R, et al. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol.1999;60: 289-299.","DOI":"10.1002\/(SICI)1096-8652(199904)60:4<289::AID-AJH7>3.0.CO;2-W"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med.1982;307: 1671-1675.","DOI":"10.1056\/NEJM198212303072703"},{"key":"2020071613314604500_REF7","doi-asserted-by":"crossref","unstructured":"Nielsen P, Fischer R, Engelhardt R, et al. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol.1995;91: 827-833.","DOI":"10.1111\/j.1365-2141.1995.tb05396.x"},{"key":"2020071613314604500_REF8","doi-asserted-by":"crossref","unstructured":"Stark DD, Bass NM, Moss AA, et al. Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology.1983;148: 743-751.","DOI":"10.1148\/radiology.148.3.6192464"},{"key":"2020071613314604500_REF9","doi-asserted-by":"crossref","unstructured":"Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol.2004;126: 736-742.","DOI":"10.1111\/j.1365-2141.2004.05104.x"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Engelhardt R, Langkowski JH, Fischer R, et al. Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging.1994;12: 999-1007.","DOI":"10.1016\/0730-725X(94)91230-T"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Wang ZJ, Haselgrove JC, Martin MB, et al. Evaluation of iron overload by single voxel MRS measurement of liver T2. J Magn Reson Imaging.2002;15: 395-400.","DOI":"10.1002\/jmri.10080"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Dixon RM, Styles P, al-Refaie FN, et al. Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy. Hepatology.1994;19: 904-910.","DOI":"10.1002\/hep.1840190416"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Kaltwasser JP, Gottschalk R, Schalk KP, Hartl W. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Brit J Haematol.1990;74: 360-363.","DOI":"10.1111\/j.1365-2141.1990.tb02596.x"},{"key":"2020071613314604500_REF14","doi-asserted-by":"crossref","unstructured":"Mavrogeni SI, Gotsis ED, Markussis V, et al. T2 relaxation time study of iron overload in b-thalassemia. Magma.1998;6: 7-12.","DOI":"10.1007\/BF02662506"},{"key":"2020071613314604500_REF15","doi-asserted-by":"crossref","unstructured":"Papakonstantinou O, Kostaridou S, Maris T, et al. Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. J Pediatr Hematol Oncol.1999;21: 142-148.","DOI":"10.1097\/00043426-199903000-00011"},{"key":"2020071613314604500_REF16","doi-asserted-by":"crossref","unstructured":"Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood.2003;101: 15-19.","DOI":"10.1182\/blood-2002-06-1723"},{"key":"2020071613314604500_REF17","doi-asserted-by":"crossref","unstructured":"Angelucci E, Giovagnoni A, Valeri G, et al. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood.1997;90: 4736-4742.","DOI":"10.1182\/blood.V90.12.4736"},{"key":"2020071613314604500_REF18","doi-asserted-by":"crossref","unstructured":"St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood.2005;105: 855-861.","DOI":"10.1182\/blood-2004-01-0177"},{"key":"2020071613314604500_REF19","doi-asserted-by":"crossref","unstructured":"Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J.2001;22: 2171-2179.","DOI":"10.1053\/euhj.2001.2822"},{"key":"2020071613314604500_REF20","doi-asserted-by":"crossref","unstructured":"Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med.1994;31: 601-610.","DOI":"10.1002\/mrm.1910310605"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Clark PR, Chua-anusorn W, St Pierre TG. Biexponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. Magn Reson Imaging.2003;21: 519-530.","DOI":"10.1016\/S0730-725X(03)00080-8"},{"key":"2020071613314604500_","doi-asserted-by":"crossref","unstructured":"Clark PR, St Pierre TG. Quantitative mapping of transverse relaxivity (1\/T(2)) in hepatic iron overload: a single spin-echo imaging methodology. Magn Reson Imaging.2000;18: 431-438.","DOI":"10.1016\/S0730-725X(00)00118-1"},{"key":"2020071613314604500_REF23","doi-asserted-by":"crossref","unstructured":"Clark PR, Chua-anusorn W, St Pierre TG. Proton transverse relaxation rate (R2) images of liver tissue: mapping local tissue iron concentrations with MRI. Magn Reson Med.2003;49: 572-575.","DOI":"10.1002\/mrm.10378"},{"key":"2020071613314604500_REF24","unstructured":"Graham JM, Paley MN, Grunewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence [published erratum appears in Brain.2001;124: 1258]."},{"key":"2020071613314604500_REF25","doi-asserted-by":"crossref","unstructured":"Miszkiel KA, Paley MN, Wilkinson ID, et al. The measurement of R2, R2* and R2\u2032 in HIV-infected patients using the prime sequence as a measure of brain iron deposition. Magn Reson Imaging.1997;15: 1113-1119.","DOI":"10.1016\/S0730-725X(97)00089-1"},{"key":"2020071613314604500_REF26","doi-asserted-by":"crossref","unstructured":"St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood.2005;105: 855-861.","DOI":"10.1182\/blood-2004-01-0177"},{"key":"2020071613314604500_REF27","doi-asserted-by":"crossref","unstructured":"Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J Magn Reson Imaging.2001;14: 72-77.","DOI":"10.1002\/jmri.1153"},{"key":"2020071613314604500_REF28","doi-asserted-by":"crossref","unstructured":"Tanimoto A, Pouliquen D, Kreft BP, Stark DD. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide. J Magn Reson Imaging.1994;4: 653-657.","DOI":"10.1002\/jmri.1880040506"},{"key":"2020071613314604500_REF29","doi-asserted-by":"crossref","unstructured":"Bulte JW, Miller GF, Vymazal J, Brooks RA, Frank JA. Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med.1997;37: 530-536.","DOI":"10.1002\/mrm.1910370409"},{"key":"2020071613314604500_REF30","doi-asserted-by":"crossref","unstructured":"Brooks RA, Moiny F, Gillis P. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med.2001;45: 1014-1020.","DOI":"10.1002\/mrm.1135"},{"key":"2020071613314604500_REF31","unstructured":"Ghugre N, Enriquez C, Coates TD, et al. Improved R2* measurements in myocardial iron overload. J Cardiovasc Magn Reson.2005;7: 32-33."},{"key":"2020071613314604500_REF32","doi-asserted-by":"crossref","unstructured":"Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging.2003;18: 33-39.","DOI":"10.1002\/jmri.10332"},{"key":"2020071613314604500_REF33","doi-asserted-by":"crossref","unstructured":"Westwood MA, Anderson LJ, Firmin DN, et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging.2003;18: 616-620.","DOI":"10.1002\/jmri.10396"},{"key":"2020071613314604500_REF34","doi-asserted-by":"crossref","unstructured":"Ambu R, Crisponi G, Sciot R, et al. Uneven hepatic iron and phosphorus distribution in beta-thalassemia. J Hepatol.1995;23: 544-549.","DOI":"10.1016\/0168-8278(95)80060-3"},{"key":"2020071613314604500_REF35","doi-asserted-by":"crossref","unstructured":"Crisponi G, Ambu R, Cristiani F, et al. Does iron concentration in a liver needle biopsy accurately reflect hepatic iron burden in beta-thalassemia? Clin Chem.2000;46: 1185-1188.","DOI":"10.1093\/clinchem\/46.8.1185"},{"key":"2020071613314604500_REF36","doi-asserted-by":"crossref","unstructured":"Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol.1996;25: 172-177.","DOI":"10.1016\/S0168-8278(96)80070-5"},{"key":"2020071613314604500_REF37","doi-asserted-by":"crossref","unstructured":"Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV. Quantitative study of the variability of hepatic iron concentrations. Clin Chem.1999;45: 340-346.","DOI":"10.1093\/clinchem\/45.3.340"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1460\/1712144\/zh801605001460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1460\/1712144\/zh801605001460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:57:23Z","timestamp":1625878643000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/4\/1460\/21527\/MRI-R2-and-R2-mapping-accurately-estimates-hepatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,15]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-10-3982","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,15]]}}}